Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 397

1.

High-Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms.

Duquesnoy RJ, Gebel HM, Woodle ES, Nickerson P, Baxter-Lowe LA, Bray RA, Claas FH, Eckels DD, Friedewald JJ, Fuggle SV, Gerlach JA, Fung JJ, Kamoun M, Middleton D, Shapiro R, Tambur AR, Taylor CJ, Tinckam K, Zeevi A.

Am J Transplant. 2015 Jul 14. doi: 10.1111/ajt.13376. [Epub ahead of print] No abstract available.

PMID:
26177785
2.

ABO-compatible liver allograft antibody-mediated rejection: an update.

Demetris AJ, Zeevi A, O'Leary JG.

Curr Opin Organ Transplant. 2015 Jun;20(3):314-24. doi: 10.1097/MOT.0000000000000194.

PMID:
25944231
3.

Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association.

Colvin MM, Cook JL, Chang P, Francis G, Hsu DT, Kiernan MS, Kobashigawa JA, Lindenfeld J, Masri SC, Miller D, O'Connell J, Rodriguez ER, Rosengard B, Self S, White-Williams C, Zeevi A; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; American Heart Association Heart Failure and Transplantation Committee of the Council on Cardiopulmonary Critical Care, Perioperative and Resuscitation; American Heart Association Heart Failure and Transplantation Committee of the Council on Cardiovascular Disease in the Young; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing; American Heart Association Heart Failure and Transplantation Committee of the Council on Cardiovascular Radiology and Intervention; American Heart Association Heart Failure and Transplantation Committee of the Council on Cardiovascular Surgery and Anesthesia.

Circulation. 2015 May 5;131(18):1608-39. doi: 10.1161/CIR.0000000000000093. Epub 2015 Apr 2. No abstract available.

PMID:
25838326
4.

Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level?

Duquesnoy RJ, Kamoun M, Baxter-Lowe LA, Woodle ES, Bray RA, Claas FH, Eckels DD, Friedewald JJ, Fuggle SV, Gebel HM, Gerlach JA, Fung JJ, Middleton D, Nickerson P, Shapiro R, Tambur AR, Taylor CJ, Tinckam K, Zeevi A.

Am J Transplant. 2015 Apr;15(4):923-30. doi: 10.1111/ajt.13167. Epub 2015 Mar 16.

PMID:
25778447
5.

A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients.

Vo AA, Zeevi A, Choi J, Cisneros K, Toyoda M, Kahwaji J, Peng A, Villicana R, Puliyanda D, Reinsmoen N, Haas M, Jordan SC.

Transplantation. 2015 Feb;99(2):299-308. doi: 10.1097/TP.0000000000000592.

PMID:
25606785
6.
7.

Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes.

Ashokkumar C, Sun Q, Ningappa M, Higgs BW, Mazariegos G, Zeevi A, Sindhi R.

Transplantation. 2015 Jan;99(1):164-70. doi: 10.1097/TP.0000000000000289.

PMID:
25531894
8.

De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.

Morrell MR, Pilewski JM, Gries CJ, Pipeling MR, Crespo MM, Ensor CR, Yousem SA, D'Cunha J, Shigemura N, Bermudez CA, McDyer JF, Zeevi A.

J Heart Lung Transplant. 2014 Dec;33(12):1288-94. doi: 10.1016/j.healun.2014.07.018. Epub 2014 Aug 23.

PMID:
25443870
9.

A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation.

Roedder S, Li L, Alonso MN, Hsieh SC, Vu MT, Dai H, Sigdel TK, Bostock I, Macedo C, Metes D, Zeevi A, Shapiro R, Salvatierra O, Scandling J, Alberu J, Engleman E, Sarwal MM.

J Am Soc Nephrol. 2014 Nov 26. pii: ASN.2013111239. [Epub ahead of print]

PMID:
25429124
10.

The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.

Roedder S, Sigdel T, Salomonis N, Hsieh S, Dai H, Bestard O, Metes D, Zeevi A, Gritsch A, Cheeseman J, Macedo C, Peddy R, Medeiros M, Vincenti F, Asher N, Salvatierra O, Shapiro R, Kirk A, Reed EF, Sarwal MM.

PLoS Med. 2014 Nov 11;11(11):e1001759. doi: 10.1371/journal.pmed.1001759. eCollection 2014 Nov. Erratum in: PLoS Med. 2015 Feb;12(2):e1001790. Zeevi, Andrea [corrected to Zeevi, Adriana]; Reed, Elaine [corrected to Reed, Elaine F].

11.

Multi-institutional Study of Outcomes After Pediatric Heart Transplantation: Candidate Gene Polymorphism Analysis of ABCC2.

Burckart GJ, Figg WD 2nd, Brooks MM, Green DJ, Troutman SM, Ferrell R, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Naftel D, Price DK, Sissung TM, Girnita DM, Zeevi A, Webber SA.

J Pediatr Pharmacol Ther. 2014 Jan;19(1):16-24. doi: 10.5863/1551-6776-19.1.16.

12.

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee.

Am J Transplant. 2014 Feb;14(2):272-83. doi: 10.1111/ajt.12590.

13.

Complement-binding anti-HLA antibodies and kidney transplantation.

Lefaucheur C, Loupy A, Zeevi A.

N Engl J Med. 2014 Jan 2;370(1):85-6. doi: 10.1056/NEJMc1313506. No abstract available.

14.

Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation.

Reed EF, Rao P, Zhang Z, Gebel H, Bray RA, Guleria I, Lunz J, Mohanakumar T, Nickerson P, Tambur AR, Zeevi A, Heeger PS, Gjertson D.

Am J Transplant. 2013 Nov;13(11):3050-1. doi: 10.1111/ajt.12462. Epub 2013 Sep 18. No abstract available.

15.

Complement-binding anti-HLA antibodies and kidney-allograft survival.

Loupy A, Lefaucheur C, Vernerey D, Prugger C, Duong van Huyen JP, Mooney N, Suberbielle C, Frémeaux-Bacchi V, Méjean A, Desgrandchamps F, Anglicheau D, Nochy D, Charron D, Empana JP, Delahousse M, Legendre C, Glotz D, Hill GS, Zeevi A, Jouven X.

N Engl J Med. 2013 Sep 26;369(13):1215-26. doi: 10.1056/NEJMoa1302506.

16.

Amnion-derived multipotent progenitor cells inhibit blood monocyte differentiation into mature dendritic cells.

Banas R, Miller C, Guzik L, Zeevi A.

Cell Transplant. 2014;23(9):1111-25. doi: 10.3727/096368913X670165.

PMID:
23849060
17.

Cylex ImmuKnow Cell Function Assay.

Zeevi A, Lunz J.

Methods Mol Biol. 2013;1034:343-51. doi: 10.1007/978-1-62703-493-7_21.

PMID:
23775749
18.

Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays.

Duquesnoy RJ, Marrari M, Jelenik L, Zeevi A, Claas FH, Mulder A.

Hum Immunol. 2013 Oct;74(10):1271-9. doi: 10.1016/j.humimm.2013.05.016. Epub 2013 Jun 12.

PMID:
23770250
19.

Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.

Reed EF, Rao P, Zhang Z, Gebel H, Bray RA, Guleria I, Lunz J, Mohanakumar T, Nickerson P, Tambur AR, Zeevi A, Heeger PS, Gjertson D.

Am J Transplant. 2013 Jul;13(7):1859-70. doi: 10.1111/ajt.12287. Epub 2013 Jun 13.

20.

Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study.

Rimmelé T, Kaynar AM, McLaughlin JN, Bishop JV, Fedorchak MV, Chuasuwan A, Peng Z, Singbartl K, Frederick DR, Zhu L, Carter M, Federspiel WJ, Zeevi A, Kellum JA.

Crit Care. 2013 Mar 26;17(2):R59. doi: 10.1186/cc12587.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk